Cardiac Amyloidosis: Current Diagnostic Strategies Using Multimodality Imaging.

Area of Science:

• Cardiology
• Nephrology
• Neurology

Background:

• Amyloidosis is a systemic disease characterized by abnormal amyloid protein deposition in organs.
• Cardiac involvement, specifically amyloid cardiomyopathy, significantly increases mortality risk.
• Light chain and transthyretin amyloidosis are the most common types affecting the heart.

Purpose of the Study:

• To highlight the importance of early and accurate diagnosis of cardiac amyloidosis.
• To emphasize the role of a systematic diagnostic approach including electrocardiography and biomarkers.
• To discuss the established utility of multimodality noninvasive imaging in differentiating amyloidosis subtypes.

Main Methods:

• Systematic diagnostic approach incorporating electrocardiography and biomarkers.
• Multimodality noninvasive imaging techniques for subtype differentiation.
• Review of recent advancements in amyloidosis treatment and monitoring.

Main Results:

• Cardiac amyloidosis presents as a restrictive cardiomyopathy with high mortality.
• Accurate diagnosis is essential for improving patient outcomes.
• Noninvasive imaging modalities are effective in distinguishing between cardiac amyloidosis subtypes.

Conclusions:

• Early diagnosis of cardiac amyloidosis through a systematic approach improves prognosis.
• Multimodality imaging is key for differentiating amyloidosis subtypes.
• Advances in treatment offer new possibilities for therapeutic monitoring and prognosis.